GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Beginning Cash Position

Genenta Science SPA (Genenta Science SPA) Beginning Cash Position : $13.31 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Beginning Cash Position?

Genenta Science SPA's Beginning Cash Position for the quarter that ended in Dec. 2023 was $13.31 Mil.

Genenta Science SPA's quarterly Beginning Cash Position declined from Dec. 2022 ($36.73 Mil) to Jun. 2023 ($32.28 Mil) and declined from Jun. 2023 ($32.28 Mil) to Dec. 2023 ($13.31 Mil).

Genenta Science SPA's annual Beginning Cash Position increased from Dec. 2021 ($17.47 Mil) to Dec. 2022 ($39.45 Mil) but then declined from Dec. 2022 ($39.45 Mil) to Dec. 2023 ($32.49 Mil).

Genenta Science SPA Beginning Cash Position Historical Data

The historical data trend for Genenta Science SPA's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Beginning Cash Position Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
8.74 24.50 17.47 39.45 32.49

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only 11.93 39.37 36.73 32.28 13.31

Genenta Science SPA Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Genenta Science SPA Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Beginning Cash Position
Comparable Companies
RVPH VXRT PMVP THRX ANIX IFRX BDTX ABEO CDXC INO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
K5F:Germany
Address
Via Olgettina No. 58, Milan, ITA, 20132
Website
https://www.genenta.com
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.